Insulin resistance in vascular endothelial cells promotes intestinal tumour formation
The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specifi...
Saved in:
| Published in | Oncogene Vol. 36; no. 35; pp. 4987 - 4996 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
31.08.2017
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0950-9232 1476-5594 1476-5594 |
| DOI | 10.1038/onc.2017.107 |
Cover
| Abstract | The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation.
In vitro
, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from
Apc
Min/+
mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in
Apc
Min/+
mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated
Apc
Min/+
mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-α. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells
in vitro
, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. |
|---|---|
| AbstractList | The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation.
In vitro
, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from
Apc
Min/+
mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in
Apc
Min/+
mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated
Apc
Min/+
mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-α. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells
in vitro
, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from Apc[sup.Min/+] mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in Apc[sup.Min/+] mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated Apc[sup.Min/+] mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-[alpha]. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells in vitro, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. Oncogene (2017) 36, 4987-4996; doi: 10.1038/onc.2017.107; published online 1 May 2017 The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from ApcMin/+ mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in ApcMin/+ mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated ApcMin/+ mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-α. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells in vitro, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from Apc[sup.Min/+] mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in Apc[sup.Min/+] mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated Apc[sup.Min/+] mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-[alpha]. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells in vitro, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from Apc mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in Apc mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated Apc mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-α. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells in vitro, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from ApcMin/+ mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in ApcMin/+ mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated ApcMin/+ mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-α. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells in vitro, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes.The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumour formation. In vitro, insulin increased proliferation of intestinal tumour epithelial cells by almost two-fold in primary culture of tumour cells from ApcMin/+ mice. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in ApcMin/+ mice did not change intestinal tumour number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumour stroma might explain the association between tumour formation and insulin resistance. To this end, we generated ApcMin/+ mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumours than controls, no change in tumour angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumour endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis factor-α. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumours. We conclude that although insulin is mitogenic for intestinal tumour cells in vitro, impaired insulin action in the tumour microenvironment may be more important in conditions where hyperinsulinaemia is secondary to insulin resistance. Insulin resistance in tumour endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterized by hyperinsulinemia and insulin resistance. Because hyperinsulinemia itself is an independent risk factor for cancer development, we examined tissue-specific insulin action in intestinal tumor formation. In vitro, insulin increased proliferation of primary cultures of intestinal tumor epithelial cells from Apc Min/+ mice by over 2-fold. Surprisingly, targeted deletion of insulin receptors in intestinal epithelial cells in Apc Min/+ mice did not change intestinal tumor number or size distribution on either a low or high-fat diet. We therefore asked whether cells in the tumor stroma might explain the association between tumor formation and insulin resistance. To this end, we generated Apc Min/+ mice with loss of insulin receptors in vascular endothelial cells. Strikingly, these mice had 42% more intestinal tumors than controls, no change in tumor angiogenesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of tumor endothelial cells. Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumor endothelial cells with intact insulin receptors and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumor necrosis factor-α. Knockout of insulin receptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased the frequency of neutrophils in tumors. We conclude that although insulin is mitogenic for intestinal tumor cells in vitro , its action on tumor cells in vivo is via signals from the tumor microenvironment. Insulin resistance in tumor endothelial cells produces an activated, proinflammatory state that promotes tumorigenesis. Improvement of endothelial dysfunction may reduce colorectal cancer risk in patients with obesity and type 2 diabetes. |
| Audience | Academic |
| Author | Wang, X Ussar, S Sørensen, D Kahn, C R Lockhart, S M Rathjen, T Rasmussen, L M Häring, M-F Bertagnolli, M M Rask-Madsen, C |
| AuthorAffiliation | 8 Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 3 Division of Clinical Chemistry and Pathobiochemistry, Department of Internal Medicine IV, University Hospital Tuebingen, Tuebingen, Germany 5 Odense University Hospital, University of Southern Denmark, Odense, Denmark 4 Novo Nordisk A/S, Måløv, Denmark 7 JRG Adipocytes and Metabolism, Institute for Diabetes and Obesity; Helmholtz Diabetes Center at Helmholtz Center Munich-Neuherberg; and German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany 6 Danish Diabetes Academy, Odense, Denmark 2 Huashan Hospital, Fudan University, People’s Republic of China 1 Joslin Diabetes Center and Harvard Medical School, Boston, MA |
| AuthorAffiliation_xml | – name: 4 Novo Nordisk A/S, Måløv, Denmark – name: 2 Huashan Hospital, Fudan University, People’s Republic of China – name: 5 Odense University Hospital, University of Southern Denmark, Odense, Denmark – name: 3 Division of Clinical Chemistry and Pathobiochemistry, Department of Internal Medicine IV, University Hospital Tuebingen, Tuebingen, Germany – name: 6 Danish Diabetes Academy, Odense, Denmark – name: 1 Joslin Diabetes Center and Harvard Medical School, Boston, MA – name: 7 JRG Adipocytes and Metabolism, Institute for Diabetes and Obesity; Helmholtz Diabetes Center at Helmholtz Center Munich-Neuherberg; and German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany – name: 8 Brigham and Women’s Hospital and Harvard Medical School, Boston, MA |
| Author_xml | – sequence: 1 givenname: X surname: Wang fullname: Wang, X organization: Joslin Diabetes Center and Harvard Medical School, Huashan Hospital, Fudan University – sequence: 2 givenname: M-F surname: Häring fullname: Häring, M-F organization: Joslin Diabetes Center and Harvard Medical School, Division of Clinical Chemistry and Pathobiochemistry, Department of Internal Medicine IV, University Hospital Tuebingen – sequence: 3 givenname: T surname: Rathjen fullname: Rathjen, T organization: Joslin Diabetes Center and Harvard Medical School, Novo Nordisk A/S – sequence: 4 givenname: S M surname: Lockhart fullname: Lockhart, S M organization: Joslin Diabetes Center and Harvard Medical School, Queen's University Belfast – sequence: 5 givenname: D surname: Sørensen fullname: Sørensen, D organization: Joslin Diabetes Center and Harvard Medical School, Odense University Hospital, University of Southern Denmark, Danish Diabetes Academy – sequence: 6 givenname: S surname: Ussar fullname: Ussar, S organization: Joslin Diabetes Center and Harvard Medical School, JRG Adipocytes and Metabolism, Institute for Diabetes and Obesity, German Center for Diabetes Research (DZD) – sequence: 7 givenname: L M surname: Rasmussen fullname: Rasmussen, L M organization: Odense University Hospital, University of Southern Denmark – sequence: 8 givenname: M M surname: Bertagnolli fullname: Bertagnolli, M M organization: Brigham and Women’s Hospital and Harvard Medical School – sequence: 9 givenname: C R surname: Kahn fullname: Kahn, C R organization: Joslin Diabetes Center and Harvard Medical School – sequence: 10 givenname: C orcidid: 0000-0002-8548-466X surname: Rask-Madsen fullname: Rask-Madsen, C email: christian.rask-madsen@joslin.harvard.edu organization: Joslin Diabetes Center and Harvard Medical School |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28459466$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1v1DAQhi1URLeFG2cUiQsHsvgjTuwLUlW1UKkSF3q2vM5k68qxFzupxL9nwpbSVgVZijXxM6_9zswROYgpAiFvGV0zKtSnFN2aU9Zh1L0gK9Z0bS2lbg7IimpJa80FPyRHpdxQSjtN-StyyFWDRNuuyNVFLHPwscpQfJlsdFBhdGuLm4PNFcQ-TdcQvA2VgxBKtctpTBMUxPA7-Ygn0zymOVdDyqOdfIqvycvBhgJv7vZjcnV-9v30a3357cvF6cll7WQjp1pstIWeWtY3G6s6oB1niqlOtXYAqWzv2gFACmCUOzQzSKCud5yrfuDAB3FMPu91d_NmhN5BnLINZpf9aPNPk6w3j0-ivzbbdGuk7JTSGgU-3Ank9GNGO2b0ZfFpI6S5GKa00K3mukH0_RP0Bj2j-2J4y6QUgv6fYlqgFldU_KW2NoDxcUj4OrdcbU4k5dgcTTuk1s9QuHoYvcMpGDz-f5Tw7mE57uvwp90IfNwDLqdSMgz3CKNmmSaD02SWacJo0eNPcOen3w3Gh_jwr6R6n1RQO24hP6jAc_wvqOjcuA |
| CitedBy_id | crossref_primary_10_1016_j_cej_2020_127801 crossref_primary_10_1111_jgh_15082 crossref_primary_10_2174_1574888X17666220331124607 crossref_primary_10_1186_s12902_020_00581_w crossref_primary_10_1055_a_1769_5032 crossref_primary_10_3892_ijmm_2020_4492 crossref_primary_10_1093_ecco_jcc_jjy112 crossref_primary_10_1152_ajpendo_00435_2020 crossref_primary_10_1186_s12889_024_18076_x crossref_primary_10_1016_j_ccr_2024_216189 crossref_primary_10_1186_s13287_021_02385_8 crossref_primary_10_1002_jcp_26902 crossref_primary_10_1007_s12020_018_1589_1 crossref_primary_10_3892_ol_2018_9731 crossref_primary_10_1186_s12885_019_5364_3 crossref_primary_10_18705_1607_419X_2019_25_3_225_231 crossref_primary_10_1016_j_atherosclerosis_2020_06_016 crossref_primary_10_4251_wjgo_v11_i11_946 crossref_primary_10_3389_fendo_2022_983160 crossref_primary_10_1186_s12885_022_10100_w crossref_primary_10_1113_JP276149 crossref_primary_10_1161_ATVBAHA_122_317476 |
| Cites_doi | 10.1126/science.2296722 10.1161/CIRCULATIONAHA.112.127514 10.1007/s001250051393 10.1016/j.metabol.2015.06.013 10.1016/j.cell.2015.05.033 10.1158/1940-6207.CAPR-11-0391 10.1016/S1097-2765(05)00015-8 10.1038/ajg.2012.180 10.1172/JCI118709 10.1002/dvdy.20643 10.1002/ijc.2910030611 10.1038/ajg.2011.301 10.2337/diabetes.49.6.999 10.1016/j.cmet.2010.03.013 10.1136/gutjnl-2016-312893 10.2337/diabetes.55.03.06.db05-0771 10.1038/nrc3215 10.1093/jnci/94.13.972 10.1007/s00125-015-3501-3 10.1038/nm0996-992 10.1007/BF00052777 10.1016/S0140-6736(08)60269-X 10.1042/CS20150143 10.1152/physrev.00030.2014 10.1073/pnas.73.12.4536 10.2337/diab.41.9.1076 10.1002/dvg.20335 10.1016/j.cell.2010.01.025 10.1172/JCI61067 10.1038/nrc2403 10.1161/ATVBAHA.108.169722 10.1172/JCI5971 10.1172/JCI15211 10.1111/j.1349-7006.1989.tb02244.x 10.1530/ERC-14-0490 10.1016/j.cmet.2015.03.001 10.1074/jbc.M204935200 10.1016/j.cmet.2015.05.020 10.1136/gutjnl-2015-310022 10.1207/S15327914NC3701_2 10.1158/0008-5472.CAN-09-2141 10.1053/j.gastro.2007.03.024 10.1111/imr.12444 10.1161/ATVBAHA.111.241919 10.1056/NEJMoa061355 10.1158/0008-5472.CAN-06-0992 10.1371/journal.pmed.1001352 10.1038/nature07602 10.1038/nrc3174 10.1053/j.gastro.2012.05.045 10.1038/nrc.2016.52 10.3390/ijms150711324 10.2337/diabetes.50.11.2611 10.1001/jama.1924.26520460003014d 10.1016/S0021-9258(20)81881-X |
| ContentType | Journal Article |
| Copyright | Macmillan Publishers Limited, part of Springer Nature. 2017 COPYRIGHT 2017 Nature Publishing Group Copyright Nature Publishing Group Aug 31, 2017 Macmillan Publishers Limited, part of Springer Nature. 2017. |
| Copyright_xml | – notice: Macmillan Publishers Limited, part of Springer Nature. 2017 – notice: COPYRIGHT 2017 Nature Publishing Group – notice: Copyright Nature Publishing Group Aug 31, 2017 – notice: Macmillan Publishers Limited, part of Springer Nature. 2017. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 5PM |
| DOI | 10.1038/onc.2017.107 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Research Library Prep Research Library Prep MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology |
| EISSN | 1476-5594 |
| EndPage | 4996 |
| ExternalDocumentID | PMC5578899 A502459907 28459466 10_1038_onc_2017_107 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIH HHS grantid: S10 OD021740 – fundername: NIDDK NIH HHS grantid: R01 DK031036 – fundername: NCI NIH HHS grantid: R21 CA185196 – fundername: NIDDK NIH HHS grantid: R37 DK031036 – fundername: NIDDK NIH HHS grantid: R01 DK033201 – fundername: NIDDK NIH HHS grantid: P30 DK036836 |
| GroupedDBID | --- -Q- 0R~ 123 29N 2WC 36B 39C 3V. 4.4 406 53G 5RE 70F 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AACDK AANZL AASML AATNV AAYZH AAZLF ABAKF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN AZQEC BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAP EBLON EBS EE. EIOEI EJD ESX F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ITC IWAJR JSO JZLTJ KQ8 L7B LK8 M0L M1P M2O M7P N9A NQJWS NXXTH O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SWTZT TAOOD TBHMF TDRGL TEORI TSG UKHRP W2D WH7 AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEFQL AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AEIIB PMFND 7TM 7TO 7U9 7XB 8FD 8FK ABRTQ FR3 H94 K9. MBDVC P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 TUS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c545t-3b9aed0a1d4ba87e0721818786afe58adc6fee53e102c095f5e0cdc228df2e2f3 |
| IEDL.DBID | 7X7 |
| ISSN | 0950-9232 1476-5594 |
| IngestDate | Thu Aug 21 13:48:48 EDT 2025 Thu Sep 04 19:48:54 EDT 2025 Fri Jul 25 09:03:15 EDT 2025 Sat Aug 23 12:51:21 EDT 2025 Tue Jun 17 21:04:22 EDT 2025 Tue Jun 10 20:23:00 EDT 2025 Thu Apr 03 07:00:02 EDT 2025 Tue Jul 01 02:45:42 EDT 2025 Thu Apr 24 22:50:44 EDT 2025 Fri Feb 21 02:38:26 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 35 |
| Language | English |
| License | Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c545t-3b9aed0a1d4ba87e0721818786afe58adc6fee53e102c095f5e0cdc228df2e2f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work |
| ORCID | 0000-0002-8548-466X |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5578899 |
| PMID | 28459466 |
| PQID | 1933962803 |
| PQPubID | 36330 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5578899 proquest_miscellaneous_1893969294 proquest_journals_2615533094 proquest_journals_1933962803 gale_infotracmisc_A502459907 gale_infotracacademiconefile_A502459907 pubmed_primary_28459466 crossref_primary_10_1038_onc_2017_107 crossref_citationtrail_10_1038_onc_2017_107 springer_journals_10_1038_onc_2017_107 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2017-08-31 |
| PublicationDateYYYYMMDD | 2017-08-31 |
| PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-31 day: 31 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England – name: New York |
| PublicationTitle | Oncogene |
| PublicationTitleAbbrev | Oncogene |
| PublicationTitleAlternate | Oncogene |
| PublicationYear | 2017 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Rask-Madsen, Kahn (CR55) 2012; 32 Flores, Rocha, Damas-Souza, Osorio-Costa, Dias, Ropelle (CR52) 2012; 143 Carothers, Moran, Cho, Redston, Bertagnolli (CR15) 2006; 66 Khandekar, Cohen, Spiegelman (CR12) 2011; 11 Makinen, Hannukainen, Karmi, Immonen, Soinio, Nelimarkka (CR32) 2015; 58 Rask-Madsen, Li, Freund, Feather, Abramov, Wu (CR18) 2010; 11 Vicent, Ilany, Kondo, Naruse, Fisher, Kisanuki (CR27) 2003; 111 Zhao, Fu, Wu, Aylor, Barrett, Cao (CR20) 2015; 129 Naruse, Rask-Madsen, Takahara, Ha, Suzuma, Way (CR53) 2006; 55 Jamieson, Clarke, Steele, Samuel, Neumann, Jung (CR38) 2012; 122 Elmunzer, Hayward, Schoenfeld, Saini, Deshpande, Waljee (CR48) 2012; 9 Muzumdar, Tasic, Miyamichi, Li, Luo (CR26) 2007; 45 Koenuma, Yamori, Tsuruo (CR31) 1989; 80 Grivennikov, Greten, Karin (CR14) 2010; 140 Laakso, Edelman, Brechtel, Baron (CR21) 1992; 41 Michael, Kulkarni, Postic, Previs, Shulman, Magnuson (CR56) 2000; 6 Giovannucci (CR10) 1995; 6 Steinberg, Chaker, Leaming, Johnson, Brechtel, Baron (CR22) 1996; 97 Tabit, Shenouda, Holbrook, Fetterman, Kiani, Frame (CR24) 2013; 127 Ish-Shalom, Christoffersen, Vorwerk, Sacerdoti-Sierra, Shymko, Naor (CR8) 1997; 40 Yoon, Keum, Zhang, Cho, Giovannucci (CR6) 2015; 64 Melder, Koenig, Witwer, Safabakhsh, Munn, Jain (CR41) 1996; 2 Treffers, Hiemstra, Kuijpers, van den Berg, Matlung (CR36) 2016; 273 Renehan, Tyson, Egger, Heller, Zwahlen (CR1) 2008; 371 Madison, Dunbar, Qiao, Braunstein, Braunstein, Gumucio (CR58) 2002; 277 Barker, Ridgway, van Es, van de Wetering, Begthel, van den Born (CR46) 2009; 457 Kim, Pham, Maloney, Rizzo, Morton, Wisse (CR19) 2008; 28 Novosyadlyy, Lann, Vijayakumar, Rowzee, Lazzarino, Fierz (CR34) 2010; 70 Raizada, Perdue (CR30) 1976; 251 Fukumura, Salehi, Witwer, Tuma, Melder, Jain (CR40) 1995; 55 Okabayashi, Ashrafian, Hasegawa, Yoo, Patel, Harling (CR49) 2012; 107 Davenport, Su, Zhao, Coleman, Smalley, Ness, Zheng, Shrubsole (CR51) 2016; 67 Rostoker, Abelson, Bitton-Worms, Genkin, Ben-Shmuel, Dakwar (CR35) 2015; 22 Kurtzhals, Schaffer, Sorensen, Kristensen, Jonassen, Schmid (CR9) 2000; 49 Targan, Feagan, Fedorak, Lashner, Panaccione, Present (CR45) 2007; 132 Chan, Arber, Burn, Chia, Elwood, Hull (CR17) 2012; 5 Steyers, Miller (CR42) 2014; 15 Bertagnolli, Eagle, Zauber, Redston, Solomon, Kim (CR16) 2006; 355 Sandhu, Dunger, Giovannucci (CR5) 2002; 94 Gallagher, LeRoith (CR3) 2015; 95 Coffelt, Wellenstein, de Visser (CR37) 2016; 16 Bickston, Behm, Tsoulis, Cheng, MacDonald, Khanna (CR43) 2014; 8 Alva, Zovein, Monvoisin, Murphy, Salazar, Harvey (CR25) 2006; 235 Gey, Thalhimer (CR28) 1924; 82 Jiang, Lin, Clemont, Feener, Hein, Igarashi (CR54) 1999; 104 Pollak (CR4) 2012; 12 Monteiro-Sepulveda, Touch, Mendes-Sa, Andre, Poitou, Allatif (CR33) 2015; 22 Temin (CR29) 1968; 3 Davenport, Su, Zhao, Coleman, Smalley, Ness, Zheng, Shrubsole (CR50) 2016; 67 Fischer, Zundler, Atreya, Rath, Voskens, Hirschmann (CR44) 2015; 65 Osborne, Bolan, Monaco, Lippman (CR7) 1976; 73 Rask-Madsen, Ihlemann, Krarup, Christiansen, Kober, Nervil Kistorp (CR23) 2001; 50 Ellis, Hicklin (CR39) 2008; 8 Moser, Pitot, Dove (CR57) 1990; 247 Yuhara, Steinmaus, Cohen, Corley, Tei, Buffler (CR2) 2011; 106 Luck, Tsai, Chung, Clemente-Casares, Ghazarian, Revelo (CR13) 2015; 21 Dow, O'Rourke, Simon, Tschaharganeh, van Es, Clevers (CR47) 2015; 161 Bruce, Wolever, Giacca (CR11) 2000; 37 HM Temin (BFonc2017107_CR29) 1968; 3 CM Steyers 3rd (BFonc2017107_CR42) 2014; 15 MK Raizada (BFonc2017107_CR30) 1976; 251 E Giovannucci (BFonc2017107_CR10) 1995; 6 James R Davenport (BFonc2017107_CR50) 2016; 67 MJ Khandekar (BFonc2017107_CR12) 2011; 11 T Jamieson (BFonc2017107_CR38) 2012; 122 D Ish-Shalom (BFonc2017107_CR8) 1997; 40 SJ Bickston (BFonc2017107_CR43) 2014; 8 C Rask-Madsen (BFonc2017107_CR23) 2001; 50 SB Coffelt (BFonc2017107_CR37) 2016; 16 J Makinen (BFonc2017107_CR32) 2015; 58 H Yuhara (BFonc2017107_CR2) 2011; 106 C Rask-Madsen (BFonc2017107_CR18) 2010; 11 RJ Melder (BFonc2017107_CR41) 1996; 2 MM Bertagnolli (BFonc2017107_CR16) 2006; 355 LW Treffers (BFonc2017107_CR36) 2016; 273 AG Renehan (BFonc2017107_CR1) 2008; 371 R Novosyadlyy (BFonc2017107_CR34) 2010; 70 R Rostoker (BFonc2017107_CR35) 2015; 22 M Pollak (BFonc2017107_CR4) 2012; 12 YS Yoon (BFonc2017107_CR6) 2015; 64 SR Targan (BFonc2017107_CR45) 2007; 132 K Naruse (BFonc2017107_CR53) 2006; 55 K Okabayashi (BFonc2017107_CR49) 2012; 107 CK Osborne (BFonc2017107_CR7) 1976; 73 M Laakso (BFonc2017107_CR21) 1992; 41 LM Ellis (BFonc2017107_CR39) 2008; 8 P Kurtzhals (BFonc2017107_CR9) 2000; 49 A Fischer (BFonc2017107_CR44) 2015; 65 BJ Elmunzer (BFonc2017107_CR48) 2012; 9 D Vicent (BFonc2017107_CR27) 2003; 111 MB Flores (BFonc2017107_CR52) 2012; 143 MD Michael (BFonc2017107_CR56) 2000; 6 LE Dow (BFonc2017107_CR47) 2015; 161 D Fukumura (BFonc2017107_CR40) 1995; 55 CE Tabit (BFonc2017107_CR24) 2013; 127 F Kim (BFonc2017107_CR19) 2008; 28 JA Alva (BFonc2017107_CR25) 2006; 235 M Koenuma (BFonc2017107_CR31) 1989; 80 HO Steinberg (BFonc2017107_CR22) 1996; 97 M Monteiro-Sepulveda (BFonc2017107_CR33) 2015; 22 SI Grivennikov (BFonc2017107_CR14) 2010; 140 WR Bruce (BFonc2017107_CR11) 2000; 37 L Zhao (BFonc2017107_CR20) 2015; 129 MS Sandhu (BFonc2017107_CR5) 2002; 94 GT Gey (BFonc2017107_CR28) 1924; 82 James R Davenport (BFonc2017107_CR51) 2016; 67 AR Moser (BFonc2017107_CR57) 1990; 247 EJ Gallagher (BFonc2017107_CR3) 2015; 95 MD Muzumdar (BFonc2017107_CR26) 2007; 45 BB Madison (BFonc2017107_CR58) 2002; 277 N Barker (BFonc2017107_CR46) 2009; 457 C Rask-Madsen (BFonc2017107_CR55) 2012; 32 AT Chan (BFonc2017107_CR17) 2012; 5 AM Carothers (BFonc2017107_CR15) 2006; 66 ZY Jiang (BFonc2017107_CR54) 1999; 104 H Luck (BFonc2017107_CR13) 2015; 21 |
| References_xml | – volume: 247 start-page: 322 year: 1990 end-page: 324 ident: CR57 article-title: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse publication-title: Science doi: 10.1126/science.2296722 – volume: 127 start-page: 86 year: 2013 end-page: 95 ident: CR24 article-title: Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.127514 – volume: 55 start-page: 4824 year: 1995 end-page: 4829 ident: CR40 article-title: Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain publication-title: Cancer Res – volume: 40 start-page: S25 issue: Suppl 2 year: 1997 end-page: S31 ident: CR8 article-title: Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor publication-title: Diabetologia doi: 10.1007/s001250051393 – volume: 64 start-page: 1324 year: 2015 end-page: 1333 ident: CR6 article-title: Hyperinsulinemia, insulin resistance and colorectal adenomas: a meta-analysis publication-title: Metabolism doi: 10.1016/j.metabol.2015.06.013 – volume: 161 start-page: 1539 year: 2015 end-page: 1552 ident: CR47 article-title: Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer publication-title: Cell doi: 10.1016/j.cell.2015.05.033 – volume: 5 start-page: 164 year: 2012 end-page: 178 ident: CR17 article-title: Aspirin in the chemoprevention of colorectal neoplasia: an overview publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-11-0391 – volume: 6 start-page: 87 year: 2000 end-page: 97 ident: CR56 article-title: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction publication-title: Mol Cell doi: 10.1016/S1097-2765(05)00015-8 – volume: 107 start-page: 1175 year: 2012 end-page: 1185 ident: CR49 article-title: Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.180 – volume: 97 start-page: 2601 year: 1996 end-page: 2610 ident: CR22 article-title: Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance publication-title: J Clin Invest doi: 10.1172/JCI118709 – volume: 235 start-page: 759 year: 2006 end-page: 767 ident: CR25 article-title: VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells publication-title: Dev Dyn doi: 10.1002/dvdy.20643 – volume: 3 start-page: 771 year: 1968 end-page: 787 ident: CR29 article-title: Carcinogenesis by avian sarcoma viruses. X. The decreased requirement for insulin-replaceable activity in serum for cell multiplication publication-title: Int J Cancer doi: 10.1002/ijc.2910030611 – volume: 106 start-page: 1911 year: 2011 end-page: 1921 ident: CR2 article-title: Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? publication-title: Am J Gastroenterol doi: 10.1038/ajg.2011.301 – volume: 49 start-page: 999 year: 2000 end-page: 1005 ident: CR9 article-title: Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use publication-title: Diabetes doi: 10.2337/diabetes.49.6.999 – volume: 11 start-page: 379 year: 2010 end-page: 389 ident: CR18 article-title: Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice publication-title: Cell Metab doi: 10.1016/j.cmet.2010.03.013 – volume: 67 start-page: 456 issue: 3 year: 2016 end-page: 465 ident: CR50 article-title: Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps publication-title: Gut doi: 10.1136/gutjnl-2016-312893 – volume: 55 start-page: 691 year: 2006 end-page: 698 ident: CR53 article-title: Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance publication-title: Diabetes doi: 10.2337/diabetes.55.03.06.db05-0771 – volume: 12 start-page: 159 year: 2012 end-page: 169 ident: CR4 article-title: The insulin and insulin-like growth factor receptor family in neoplasia: an update publication-title: Nat Rev Cancer doi: 10.1038/nrc3215 – volume: 94 start-page: 972 year: 2002 end-page: 980 ident: CR5 article-title: Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.13.972 – volume: 58 start-page: 1055 year: 2015 end-page: 1062 ident: CR32 article-title: Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery publication-title: Diabetologia doi: 10.1007/s00125-015-3501-3 – volume: 2 start-page: 992 year: 1996 end-page: 997 ident: CR41 article-title: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium publication-title: Nat Med doi: 10.1038/nm0996-992 – volume: 6 start-page: 164 year: 1995 end-page: 179 ident: CR10 article-title: Insulin and colon cancer publication-title: Cancer Causes Control: CCC doi: 10.1007/BF00052777 – volume: 371 start-page: 569 year: 2008 end-page: 578 ident: CR1 article-title: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies publication-title: Lancet doi: 10.1016/S0140-6736(08)60269-X – volume: 129 start-page: 1025 year: 2015 end-page: 1036 ident: CR20 article-title: Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity publication-title: Clin Sci (Lond) doi: 10.1042/CS20150143 – volume: 95 start-page: 727 year: 2015 end-page: 748 ident: CR3 article-title: Obesity and diabetes: the increased risk of cancer and cancer-related mortality publication-title: Physiol Rev doi: 10.1152/physrev.00030.2014 – volume: 73 start-page: 4536 year: 1976 end-page: 4540 ident: CR7 article-title: Hormone responsive human breast cancer in long-term tissue culture: effect of insulin publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.73.12.4536 – volume: 41 start-page: 1076 year: 1992 end-page: 1083 ident: CR21 article-title: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM publication-title: Diabetes doi: 10.2337/diab.41.9.1076 – volume: 45 start-page: 593 year: 2007 end-page: 605 ident: CR26 article-title: A global double-fluorescent Cre reporter mouse publication-title: Genesis doi: 10.1002/dvg.20335 – volume: 8 start-page: CD007571 year: 2014 ident: CR43 article-title: Vedolizumab for induction and maintenance of remission in ulcerative colitis publication-title: Cochrane Database Syst Rev – volume: 140 start-page: 883 year: 2010 end-page: 899 ident: CR14 article-title: Immunity, inflammation, and cancer publication-title: Cell doi: 10.1016/j.cell.2010.01.025 – volume: 122 start-page: 3127 year: 2012 end-page: 3144 ident: CR38 article-title: Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis publication-title: J Clin Invest doi: 10.1172/JCI61067 – volume: 8 start-page: 579 year: 2008 end-page: 591 ident: CR39 article-title: VEGF-targeted therapy: mechanisms of anti-tumour activity publication-title: Nat Rev Cancer doi: 10.1038/nrc2403 – volume: 28 start-page: 1982 year: 2008 end-page: 1988 ident: CR19 article-title: Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.108.169722 – volume: 104 start-page: 447 year: 1999 end-page: 457 ident: CR54 article-title: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats publication-title: J Clin Invest doi: 10.1172/JCI5971 – volume: 111 start-page: 1373 year: 2003 end-page: 1380 ident: CR27 article-title: The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance publication-title: J Clin Invest doi: 10.1172/JCI15211 – volume: 80 start-page: 51 year: 1989 end-page: 58 ident: CR31 article-title: Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26 publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.1989.tb02244.x – volume: 22 start-page: 145 year: 2015 end-page: 157 ident: CR35 article-title: Highly specific role of the insulin receptor in breast cancer progression publication-title: Endocr Relat Cancer doi: 10.1530/ERC-14-0490 – volume: 21 start-page: 527 year: 2015 end-page: 542 ident: CR13 article-title: Regulation of obesity-related insulin resistance with gut anti-inflammatory agents publication-title: Cell Metab doi: 10.1016/j.cmet.2015.03.001 – volume: 67 start-page: 456 issue: 3 year: 2016 end-page: 465 ident: CR51 article-title: Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps publication-title: Gut doi: 10.1136/gutjnl-2016-312893 – volume: 277 start-page: 33275 year: 2002 end-page: 33283 ident: CR58 article-title: Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine publication-title: J Biol Chem doi: 10.1074/jbc.M204935200 – volume: 251 start-page: 6445 year: 1976 end-page: 6455 ident: CR30 article-title: Mitogen receptors in chick embryo fibroblasts. Kinetics, specificity, unmasking, and synthesis of 125I-insulin binding sites publication-title: J Biol Chem – volume: 22 start-page: 113 year: 2015 end-page: 124 ident: CR33 article-title: Jejunal T cell inflammation in human obesity correlates with decreased enterocyte insulin signaling publication-title: Cell Metab doi: 10.1016/j.cmet.2015.05.020 – volume: 65 start-page: 1642 year: 2015 end-page: 1664 ident: CR44 article-title: Differential effects of alpha4beta7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut publication-title: Gut doi: 10.1136/gutjnl-2015-310022 – volume: 37 start-page: 19 year: 2000 end-page: 26 ident: CR11 article-title: Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance publication-title: Nutr Cancer doi: 10.1207/S15327914NC3701_2 – volume: 70 start-page: 741 year: 2010 end-page: 751 ident: CR34 article-title: Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-2141 – volume: 132 start-page: 1672 year: 2007 end-page: 1683 ident: CR45 article-title: Natalizumab for the treatment of active Crohn’s disease: results of the ENCORE Trial publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.024 – volume: 273 start-page: 312 year: 2016 end-page: 328 ident: CR36 article-title: Neutrophils in cancer publication-title: Immunol Rev doi: 10.1111/imr.12444 – volume: 32 start-page: 2052 year: 2012 end-page: 2059 ident: CR55 article-title: Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.111.241919 – volume: 355 start-page: 873 year: 2006 end-page: 884 ident: CR16 article-title: Celecoxib for the prevention of sporadic colorectal adenomas publication-title: N Engl J Med doi: 10.1056/NEJMoa061355 – volume: 66 start-page: 6432 year: 2006 end-page: 6438 ident: CR15 article-title: Changes in antitumor response in C57BL/6 J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-0992 – volume: 9 start-page: e1001352 year: 2012 ident: CR48 article-title: Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials publication-title: PLoS Med doi: 10.1371/journal.pmed.1001352 – volume: 457 start-page: 608 year: 2009 end-page: 611 ident: CR46 article-title: Crypt stem cells as the cells-of-origin of intestinal cancer publication-title: Nature doi: 10.1038/nature07602 – volume: 11 start-page: 886 year: 2011 end-page: 895 ident: CR12 article-title: Molecular mechanisms of cancer development in obesity publication-title: Nat Rev Cancer doi: 10.1038/nrc3174 – volume: 143 start-page: 741 year: 2012 end-page: 753 ident: CR52 article-title: Obesity-induced increase in tumor necrosis factor-alpha leads to development of colon cancer in mice publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.05.045 – volume: 16 start-page: 431 year: 2016 end-page: 446 ident: CR37 article-title: Neutrophils in cancer: neutral no more publication-title: Nat Rev Cancer doi: 10.1038/nrc.2016.52 – volume: 15 start-page: 11324 year: 2014 end-page: 11349 ident: CR42 article-title: Endothelial dysfunction in chronic inflammatory diseases publication-title: Int J Mol Sci doi: 10.3390/ijms150711324 – volume: 50 start-page: 2611 year: 2001 end-page: 2618 ident: CR23 article-title: Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease publication-title: Diabetes doi: 10.2337/diabetes.50.11.2611 – volume: 82 start-page: 1609 year: 1924 ident: CR28 article-title: Observations on the effects of insulin introduced into the medium of tissue cultures publication-title: JAMA doi: 10.1001/jama.1924.26520460003014d – volume: 28 start-page: 1982 year: 2008 ident: BFonc2017107_CR19 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.108.169722 – volume: 106 start-page: 1911 year: 2011 ident: BFonc2017107_CR2 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2011.301 – volume: 82 start-page: 1609 year: 1924 ident: BFonc2017107_CR28 publication-title: JAMA doi: 10.1001/jama.1924.26520460003014d – volume: 2 start-page: 992 year: 1996 ident: BFonc2017107_CR41 publication-title: Nat Med doi: 10.1038/nm0996-992 – volume: 65 start-page: 1642 year: 2015 ident: BFonc2017107_CR44 publication-title: Gut doi: 10.1136/gutjnl-2015-310022 – volume: 58 start-page: 1055 year: 2015 ident: BFonc2017107_CR32 publication-title: Diabetologia doi: 10.1007/s00125-015-3501-3 – volume: 132 start-page: 1672 year: 2007 ident: BFonc2017107_CR45 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.024 – volume: 12 start-page: 159 year: 2012 ident: BFonc2017107_CR4 publication-title: Nat Rev Cancer doi: 10.1038/nrc3215 – volume: 107 start-page: 1175 year: 2012 ident: BFonc2017107_CR49 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2012.180 – volume: 161 start-page: 1539 year: 2015 ident: BFonc2017107_CR47 publication-title: Cell doi: 10.1016/j.cell.2015.05.033 – volume: 277 start-page: 33275 year: 2002 ident: BFonc2017107_CR58 publication-title: J Biol Chem doi: 10.1074/jbc.M204935200 – volume: 49 start-page: 999 year: 2000 ident: BFonc2017107_CR9 publication-title: Diabetes doi: 10.2337/diabetes.49.6.999 – volume: 16 start-page: 431 year: 2016 ident: BFonc2017107_CR37 publication-title: Nat Rev Cancer doi: 10.1038/nrc.2016.52 – volume: 5 start-page: 164 year: 2012 ident: BFonc2017107_CR17 publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-11-0391 – volume: 122 start-page: 3127 year: 2012 ident: BFonc2017107_CR38 publication-title: J Clin Invest doi: 10.1172/JCI61067 – volume: 111 start-page: 1373 year: 2003 ident: BFonc2017107_CR27 publication-title: J Clin Invest doi: 10.1172/JCI15211 – volume: 80 start-page: 51 year: 1989 ident: BFonc2017107_CR31 publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.1989.tb02244.x – volume: 11 start-page: 886 year: 2011 ident: BFonc2017107_CR12 publication-title: Nat Rev Cancer doi: 10.1038/nrc3174 – volume: 127 start-page: 86 year: 2013 ident: BFonc2017107_CR24 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.127514 – volume: 104 start-page: 447 year: 1999 ident: BFonc2017107_CR54 publication-title: J Clin Invest doi: 10.1172/JCI5971 – volume: 9 start-page: e1001352 year: 2012 ident: BFonc2017107_CR48 publication-title: PLoS Med doi: 10.1371/journal.pmed.1001352 – volume: 355 start-page: 873 year: 2006 ident: BFonc2017107_CR16 publication-title: N Engl J Med doi: 10.1056/NEJMoa061355 – volume: 3 start-page: 771 year: 1968 ident: BFonc2017107_CR29 publication-title: Int J Cancer doi: 10.1002/ijc.2910030611 – volume: 129 start-page: 1025 year: 2015 ident: BFonc2017107_CR20 publication-title: Clin Sci (Lond) doi: 10.1042/CS20150143 – volume: 21 start-page: 527 year: 2015 ident: BFonc2017107_CR13 publication-title: Cell Metab doi: 10.1016/j.cmet.2015.03.001 – volume: 70 start-page: 741 year: 2010 ident: BFonc2017107_CR34 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-2141 – volume: 11 start-page: 379 year: 2010 ident: BFonc2017107_CR18 publication-title: Cell Metab doi: 10.1016/j.cmet.2010.03.013 – volume: 8 start-page: CD007571 year: 2014 ident: BFonc2017107_CR43 publication-title: Cochrane Database Syst Rev – volume: 50 start-page: 2611 year: 2001 ident: BFonc2017107_CR23 publication-title: Diabetes doi: 10.2337/diabetes.50.11.2611 – volume: 95 start-page: 727 year: 2015 ident: BFonc2017107_CR3 publication-title: Physiol Rev doi: 10.1152/physrev.00030.2014 – volume: 73 start-page: 4536 year: 1976 ident: BFonc2017107_CR7 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.73.12.4536 – volume: 6 start-page: 87 year: 2000 ident: BFonc2017107_CR56 publication-title: Mol Cell doi: 10.1016/S1097-2765(05)00015-8 – volume: 371 start-page: 569 year: 2008 ident: BFonc2017107_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(08)60269-X – volume: 40 start-page: S25 issue: Suppl 2 year: 1997 ident: BFonc2017107_CR8 publication-title: Diabetologia doi: 10.1007/s001250051393 – volume: 235 start-page: 759 year: 2006 ident: BFonc2017107_CR25 publication-title: Dev Dyn doi: 10.1002/dvdy.20643 – volume: 22 start-page: 145 year: 2015 ident: BFonc2017107_CR35 publication-title: Endocr Relat Cancer doi: 10.1530/ERC-14-0490 – volume: 273 start-page: 312 year: 2016 ident: BFonc2017107_CR36 publication-title: Immunol Rev doi: 10.1111/imr.12444 – volume: 247 start-page: 322 year: 1990 ident: BFonc2017107_CR57 publication-title: Science doi: 10.1126/science.2296722 – volume: 97 start-page: 2601 year: 1996 ident: BFonc2017107_CR22 publication-title: J Clin Invest doi: 10.1172/JCI118709 – volume: 251 start-page: 6445 year: 1976 ident: BFonc2017107_CR30 publication-title: J Biol Chem doi: 10.1016/S0021-9258(20)81881-X – volume: 22 start-page: 113 year: 2015 ident: BFonc2017107_CR33 publication-title: Cell Metab doi: 10.1016/j.cmet.2015.05.020 – volume: 55 start-page: 4824 year: 1995 ident: BFonc2017107_CR40 publication-title: Cancer Res – volume: 45 start-page: 593 year: 2007 ident: BFonc2017107_CR26 publication-title: Genesis doi: 10.1002/dvg.20335 – volume: 55 start-page: 691 year: 2006 ident: BFonc2017107_CR53 publication-title: Diabetes doi: 10.2337/diabetes.55.03.06.db05-0771 – volume: 94 start-page: 972 year: 2002 ident: BFonc2017107_CR5 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/94.13.972 – volume: 143 start-page: 741 year: 2012 ident: BFonc2017107_CR52 publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.05.045 – volume: 37 start-page: 19 year: 2000 ident: BFonc2017107_CR11 publication-title: Nutr Cancer doi: 10.1207/S15327914NC3701_2 – volume: 140 start-page: 883 year: 2010 ident: BFonc2017107_CR14 publication-title: Cell doi: 10.1016/j.cell.2010.01.025 – volume: 8 start-page: 579 year: 2008 ident: BFonc2017107_CR39 publication-title: Nat Rev Cancer doi: 10.1038/nrc2403 – volume: 67 start-page: 456 issue: 3 year: 2016 ident: BFonc2017107_CR51 publication-title: Gut doi: 10.1136/gutjnl-2016-312893 – volume: 457 start-page: 608 year: 2009 ident: BFonc2017107_CR46 publication-title: Nature doi: 10.1038/nature07602 – volume: 64 start-page: 1324 year: 2015 ident: BFonc2017107_CR6 publication-title: Metabolism doi: 10.1016/j.metabol.2015.06.013 – volume: 15 start-page: 11324 year: 2014 ident: BFonc2017107_CR42 publication-title: Int J Mol Sci doi: 10.3390/ijms150711324 – volume: 32 start-page: 2052 year: 2012 ident: BFonc2017107_CR55 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.111.241919 – volume: 66 start-page: 6432 year: 2006 ident: BFonc2017107_CR15 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-0992 – volume: 67 start-page: 456 issue: 3 year: 2016 ident: BFonc2017107_CR50 publication-title: Gut doi: 10.1136/gutjnl-2016-312893 – volume: 6 start-page: 164 year: 1995 ident: BFonc2017107_CR10 publication-title: Cancer Causes Control: CCC doi: 10.1007/BF00052777 – volume: 41 start-page: 1076 year: 1992 ident: BFonc2017107_CR21 publication-title: Diabetes doi: 10.2337/diab.41.9.1076 |
| SSID | ssj0007902 |
| Score | 2.3880188 |
| Snippet | The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by... The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterized by... |
| SourceID | pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4987 |
| SubjectTerms | 13/106 13/31 13/95 45/41 631/1647/334 631/67/327 631/80/79 64/110 96/95 Angiogenesis Animals Anti-inflammatory agents Apoptosis Cancer Carcinogenesis - genetics Carcinogenesis - metabolism Carcinogenesis - pathology Care and treatment Cell adhesion & migration Cell adhesion molecules Cell Biology Cell culture Cell proliferation Clonal deletion Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - genetics Colorectal Neoplasms - metabolism Colorectal Neoplasms - pathology Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Dosage and administration Endothelial cells Endothelial Cells - metabolism Endothelial Cells - pathology Epithelial cells Gene deletion Gene Knockdown Techniques High fat diet Human Genetics Inflammation Insulin Insulin - metabolism Insulin receptors Insulin Resistance Internal Medicine Intestine Leukocytes (neutrophilic) Low fat diet Medicine Medicine & Public Health Mice Mice, Inbred C57BL Mice, Knockout Microenvironments Nutrient deficiency Obesity Oncology original-article Patients Receptor, Insulin - genetics Receptor, Insulin - metabolism Risk factors Rodents Signal Transduction Size distribution Stroma Tumor Microenvironment Tumor necrosis factor Tumorigenesis Tumors Type 2 diabetes Vascular cell adhesion molecule 1 Vascular Cell Adhesion Molecule-1 - biosynthesis |
| Title | Insulin resistance in vascular endothelial cells promotes intestinal tumour formation |
| URI | https://link.springer.com/article/10.1038/onc.2017.107 https://www.ncbi.nlm.nih.gov/pubmed/28459466 https://www.proquest.com/docview/1933962803 https://www.proquest.com/docview/2615533094 https://www.proquest.com/docview/1893969294 https://pubmed.ncbi.nlm.nih.gov/PMC5578899 |
| Volume | 36 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJmAvCMpXYExB4uMBRUviOE6e0Kg2DaRNCFGpb1FiO2LSlhbaPvDf73eJE5Zq8FLJ8slxfee7n33nO6K3EJMwshxTZWQZJEaFQQ7LF4g00UKLOhI1v0Y-O09PZ8nXuZy7C7eVC6vsdWKrqM1C8x35YcwONBy-8-TT8lfAVaPYu-pKaNyl3QhIhEs3qPlw4ApVF3MIFIEZADq4wPdQZIeLhvMXRgotNTJJ24r5hmXajprccp22FunkET10UNI_6nj_mO7YZkL3uuKSfyb0YNrXcpvQ_TPnQn9Csy9d9LmPczZjRzDdR6uPSPVtY_hR1iXk0udb_ZW_bCP27Mrn1BLQCPzR9eYKn_eHp49PaXZy_GN6GrjaCoEGZloHospLa8IyMklVZspymjTYbpWlZW1lVhqd1tZKYQFANBawljbURsdxZurYxrV4RjvNorEvyOdiipEsrawZjoSmSmVVyjxWWogc_PboY7-8hXaJx7n-xWXROsBFVoAZBTMDLeXRu4F62SXc-AfdB-ZUwfsQo-nSPSfAnDijVXEk2akMWwvK_RElll6Pu3teF27_rgoIk8hTrtx1a_dfYfTozdDNA3PIWmMXGwwBJJinQJ-ged5JzvCHgAkkJ_b3SI1kaiDgpN_jnubiZ5v8W0LF4ozs0fte-m7M-pZ1evn_-b-iPabsbsn3aWf9e2NfA2atq4N2L-E3m0YHtPv5-Pzb92sUNChr |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIigXBMsrUCBIFA4oahLHcXJAqCpUu7TbU1faW0hsRyCV7MLuCvVP8Rv5Ji-6q8KtR8sTx_HMeD5nxjNEryEmfmA5psrI3IuM8r0Uls8TcaSFFmUgSr6NPD6Nh5Po81ROt-h3dxeGwyq7PbHeqM1M8z_y_ZAdaDh8p9GH-Q-Pq0axd7UrodGIxbG9-IUj2-L96CP4uxeGR5_ODodeW1XA00ALS08UaW6NnwcmKvJEWU4QBqulkjgvrUxyo-PSWiksTK8GACml9bXRYZiYMrRhKTDuDboZsYsR-qOm_QHPV02MIx7CFwOqtIH2vkj2ZxXnSwwUWmrNBG4agkuWcDNKc8NVW1vAo3t0t4Wu7kEja_dpy1YDutUUs7wY0M5hVztuQLfHrcv-AU1GTbS7i3M9Y1UImYtWFwHr2srwJbBz6IHLXoSFO68jBO3C5VQW2IH4pcvVd7ze7a9aPqTJtaz6I9quZpV9Qi4XbwxkbmXJ8Mc3RSyLXKah0kKkkC-H3nXLm-k20TnX2zjPaoe7SDIwI2NmoKUc2uup502Cj3_QvWVOZaz3GE3n7fUFzIkzaGUHkp3YsO2g3F2jxNLr9e6O11m7XywywGiRxlwp7Mruv8Lv0Ku-mwfmELnKzlYYAsgzjYF2QfO4kZz-g4BBJBcScEityVRPwEnG13uqb1_rZOMSWzrO5A696aTv0qyvWKen_5__S9oZno1PspPR6fEzusNPNX_od2l7-XNlnwPiLYsXtV659OW6FfkP6_lkiQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTWy8IChfgQFGYvCAoiZxHScPExrbqpWxakJU2ltwbEdDGmmhrdD-Rf4q7hInLNXgbY-WL45jn-9-zn0BvEY2CUJLPlVGKH9gZOCnqPl8Hg8017wIeUHRyCfj-Ggy-HgmztbgdxMLQ26VjUysBLWZavpH3o_IgIaX73TQL5xbxOnB8P3sh08VpMjS2pTTUK7Mgtmt0o25II9je_kLr3Pz3dEB7v1OFA0Pv-wf-a7igK8RSSx8nqfKmkCFZpCrRFpKHoYaTSaxKqxIlNFxYa3gFtWyRnBSCBtoo6MoMUVko4LjuLdgQ6LWx4vgxofD8ennVi_I2gMSH8P1QCDj3PADnvSnJWVTDCW2ZEdBrqqJK3py1YdzxZBb6cfhPbjrgC3bqznxPqzZsge361KXlz3Y2m8qy_Vg88QZ9B_AZFT7wjO89ROSRRZk2Gr8Y5ktDYWIXeApYWRjmLNZ5T9o54wSXaB8opcult_x9awNxHwIkxtZ90ewXk5L-wQYlXYMhbKiIHAUmDwWuRJpJDXnKXKfB--a5c20S4NO1Tgussocz5MMNyOjzcCW9GCnpZ7V6T_-QfeWdiojqYCjaeWCG3BOlF8r2xNk4kbNj5TbHUpcet3tbvY6c9JkniHI5mlMdcSu7f57NDx41XbTwORAV9rpEodAXJrGiIWR5nHNOe0HIUIRVGbAA9nhqZaAUpB3e8pv51UqcoECH2_sHrxpuO_KrK9Zp6f_n_9L2MRDnX0ajY-fwR16qP59vw3ri59L-xzx3yJ_4Q4Wg683fZb_AGuYb2Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Insulin+resistance+in+vascular+endothelial+cells+promotes+intestinal+tumour+formation&rft.jtitle=Oncogene&rft.au=Wang%2C+X&rft.au=H%C3%A4ring%2C+M-F&rft.au=Rathjen%2C+T&rft.au=Lockhart%2C+S+M&rft.date=2017-08-31&rft.issn=1476-5594&rft.eissn=1476-5594&rft.volume=36&rft.issue=35&rft.spage=4987&rft_id=info:doi/10.1038%2Fonc.2017.107&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |